-
The number of previous acute exacerbations of chronic bronchitis (AECBs) and the baseline FEV1 level are potent prognostic factors of the short and long-term outcomes of AECB.
-
-
Survey data suggest more than 4.1 million Americans have antibodies to Hepatitis C, and 3.2 million have chronic infection.
-
Low-dose aspirin plus celecoxib led to ulcers in 19% of recipients vs 27% ulcers in patients receiving naproxen and low-dose aspirin. The group receiving low-dose aspirin plus placebo had 8% ulcer development.
-
The FDA has licensed a new vaccine to reduce the risk of shingles in the people 60 years of age and older.
-
That air travel is associated with increased risk of deep venous thrombosis (DVT) is well established; Obesity is a recognized risk factor for GERD; and Anti-TNF antibody (aTNFa) therapy offers significant benefit to sufferers of rheumatoid arthritis (RA).
-
Pulmonary embolism occurs commonly in patients with unexplained exacerbations of chronic obstructive pulmonary disease.
-
All of the currently available non-invasive techniques for carotid artery imaging give accurate results when there is a high-grade stenosis (70-99%), but contrast-enhanced MRA is slightly more sensitive.
-
The FDA has approved a new agent for smoking cessation. Varenicline blocks the action of nicotine but provides a lower level of stimulation of dopamine release to reduce craving and withdrawal symptoms.
-
The TNT study (Treat to New Targets) demonstrated that intensive lipid lowering (ILL) with atorvastatin 80 mg/d in patients with stable coronary artery disease (CAD) provided more benefit than simply achieving an LDL of 100 mg/dL with atorvastatin 10 mg/d.
